Robert Langer: Moderna Co-Founder on Biotech, Drug Delivery & AI in Medicine

Robert Langer's Pioneering Career

• 💡 MIT Institute Professor and Moderna co-founder, Robert Langer is recognized for his prolific inventions and numerous awards in science and entrepreneurship.
• 🚀 Transitioned from chemical engineering to medicine in 1974, driven by a desire to help people and applying his background to solve medical challenges.

Innovations in Drug Delivery

• 🔬 Pioneered drug delivery systems for large molecules like proteins, DNA, and RNA, a breakthrough previously considered impossible.
• ✅ This research enabled the development of blood vessel inhibitors and laid the foundation for many modern drug delivery applications, now widely used.

Founding Moderna and Impact

• 🧬 His foundational work on nanoparticles for RNA delivery was crucial for Moderna, which he co-founded with others, including Derek Rossi, Ken Chien, Noubar Afeyan, and Stéphane Bancel.
• 🎯 Moderna's success, particularly with the mRNA vaccine during the pandemic, demonstrated the world-changing potential of this technology.

Current Research & Global Health

• 🌱 Collaborates with the Gates Foundation on drug delivery solutions for the developing world, focusing on single-dose vaccines and stable, long-lasting treatments.
• 🌍 Developing innovative solutions like vitamin A in bouillon for nutrition in places like Nigeria and pills lasting weeks or months to improve patient compliance.

Tissue Engineering & AI in Medicine

• 🛠️ Actively involved in tissue and organ engineering, leading to advancements such as new skin for burn victims and blood vessels for soldiers.
• 🧠 Research includes "organs on a chip," like personalized brains on a chip, for high-throughput drug discovery for diseases such as Alzheimer's and ALS.
• 🤖 Views Artificial Intelligence as a powerful tool for biomedical research, especially when applied to large, high-quality datasets for drug solubility, image analysis, and diagnosis.

Outlook on Biotech & Entrepreneurship

• 📈 Acknowledges the current biotech sector downturn but remains optimistic for its recovery, citing the strength of great science and entrepreneurship.
• 🔑 Emphasizes a "never give up" attitude and entrepreneurial spirit, drawing inspiration from historical figures like Milton Hershey's persistence through failures.